Cecconi Maurizio, Piovani Daniele, Brunetta Enrico, Aghemo Alessio, Greco Massimiliano, Ciccarelli Michele, Angelini Claudio, Voza Antonio, Omodei Paolo, Vespa Edoardo, Pugliese Nicola, Parigi Tommaso Lorenzo, Folci Marco, Danese Silvio, Bonovas Stefanos
Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan, Italy.
Humanitas Clinical and Research Center - IRCCS -, 20089 Rozzano, Milan, Italy.
J Clin Med. 2020 May 20;9(5):1548. doi: 10.3390/jcm9051548.
We described features of hospitalized Covid-19 patients and identified predictors of clinical deterioration. We included patients consecutively admitted at Humanitas Research Hospital (Rozzano, Milan, Italy); retrospectively extracted demographic; clinical; laboratory and imaging findings at admission; used survival methods to identify factors associated with clinical deterioration (defined as intensive care unit (ICU) transfer or death), and developed a prognostic index. Overall; we analyzed 239 patients (29.3% females) with a mean age of 63.9 (standard deviation [SD]; 14.0) years. Clinical deterioration occurred in 70 patients (29.3%), including 41 (17.2%) ICU transfers and 36 (15.1%) deaths. The most common symptoms and signs at admission were cough (77.8%) and elevated respiratory rate (34.1%), while 66.5% of patients had at least one coexisting medical condition. Imaging frequently revealed ground-glass opacity (68.9%) and consolidation (23.8%). Age; increased respiratory rate; abnormal blood gas parameters and imaging findings; coexisting coronary heart disease; leukocytosis; lymphocytopenia; and several laboratory parameters (elevated procalcitonin; interleukin-6; serum ferritin; C-reactive protein; aspartate aminotransferase; lactate dehydrogenase; creatinine; fibrinogen; troponin-I; and D-dimer) were significant predictors of clinical deterioration. We suggested a prognostic index to assist risk-stratification (C-statistic; 0.845; 95% CI; 0.802‒0.887). These results could aid early identification and management of patients at risk, who should therefore receive additional monitoring and aggressive supportive care.
我们描述了新冠肺炎住院患者的特征,并确定了临床恶化的预测因素。我们纳入了连续入住胡马纳塔斯研究医院(意大利米兰罗扎诺)的患者;回顾性提取了人口统计学、临床、入院时的实验室和影像学检查结果;采用生存分析方法确定与临床恶化(定义为转入重症监护病房(ICU)或死亡)相关的因素,并制定了一个预后指数。总体而言,我们分析了239例患者(女性占29.3%),平均年龄为63.9岁(标准差[SD]:14.0)。70例患者(29.3%)出现临床恶化,包括41例(17.2%)转入ICU和36例(15.1%)死亡。入院时最常见的症状和体征为咳嗽(77.8%)和呼吸频率升高(34.1%),而66.5%的患者至少有一种并存疾病。影像学检查常显示磨玻璃影(68.9%)和实变(23.8%)。年龄、呼吸频率增加、血气参数和影像学检查结果异常、并存冠心病、白细胞增多、淋巴细胞减少以及一些实验室参数(降钙素原、白细胞介素-6、血清铁蛋白、C反应蛋白、天门冬氨酸氨基转移酶、乳酸脱氢酶、肌酐、纤维蛋白原、肌钙蛋白I和D-二聚体升高)是临床恶化的显著预测因素。我们提出了一个预后指数以协助进行风险分层(C统计量:0.845;95%CI:0.802‒0.887)。这些结果有助于早期识别和管理高危患者,因此这些患者应接受额外监测和积极的支持治疗。